These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6063421)

  • 41. Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats.
    Ward JR; Cloud RS
    J Pharmacol Exp Ther; 1966 Apr; 152(1):116-21. PubMed ID: 5937395
    [No Abstract]   [Full Text] [Related]  

  • 42. Hydroxychloroquine versus chloroquine in polymorphic light eruption.
    Singh G; Archana G
    Indian J Dermatol Venereol Leprol; 2008; 74(4):396-7. PubMed ID: 18797074
    [No Abstract]   [Full Text] [Related]  

  • 43. [Macular leprosy of Lucio--antimalarials in leprotic reaction].
    Padilla HC
    Dermatol Int; 1965; 4(3):147-50. PubMed ID: 5877280
    [No Abstract]   [Full Text] [Related]  

  • 44. Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers.
    Smith ER; Klein-Schwartz W
    J Emerg Med; 2005 May; 28(4):437-43. PubMed ID: 15837026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Influence of chloroquine and hydroxychloroquine on the evolution of postischemic movement disorders].
    Rosner I; Malhie P
    Therapie; 1967; 22(2):345-54. PubMed ID: 6063421
    [No Abstract]   [Full Text] [Related]  

  • 49. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
    Wallace DJ
    Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.
    Furst DE
    Lupus; 1996 Jun; 5 Suppl 1():S11-5. PubMed ID: 8803904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
    Houpt JB
    J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.